Marek Zurawski
EMEA Portfolio & Alliance Lead - Precision Medicine Johnson & Johnson Innovative Medicine
Seminars
Tuesday 31st March 2026
From Bench to Bedside: Ensuring Adoption of Clinical Biomarkers
12:30 pm
- Understanding drivers and barriers for the adoption of biomarkers
- Sharing J&Js approach to market shaping through agility and partnerships
- Future perspectives on how to manage adoption in the evolving landscape and new CDx modalities, such as AI
